1202577-61-4 Usage
General Description
Trans-(4-(trifluoromethyl)cyclohexyl)methanol is a chemical compound that belongs to the family of cyclohexanol derivatives. It is a colorless liquid with a molecular formula of C8H13F3O. trans-(4-(trifluoromethyl)cyclohexyl)methanol is often used as a pharmaceutical intermediate and a building block in the synthesis of various pharmaceuticals and agrochemicals. Additionally, it is known for its unique structural and physicochemical properties, which make it useful in the development of new materials and applications in the field of organic chemistry. Its trifluoromethyl group makes it highly valuable in medicinal chemistry and drug discovery, as it can enhance the biological activity and pharmacokinetic properties of potential drug candidates.
Check Digit Verification of cas no
The CAS Registry Mumber 1202577-61-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,0,2,5,7 and 7 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1202577-61:
(9*1)+(8*2)+(7*0)+(6*2)+(5*5)+(4*7)+(3*7)+(2*6)+(1*1)=124
124 % 10 = 4
So 1202577-61-4 is a valid CAS Registry Number.
1202577-61-4Relevant articles and documents
ANTIVIRAL COMPOUNDS
-
Paragraph 0282, (2021/08/27)
The present disclosure provides compounds for treating a variety of diseases, such as respiratory syncytial virus (RSV), HRV, hMPV, ebola, Zika, West Nile, Dengue, and HCV.
NOVEL 3, 5-DISUBSTITUTED PYRIDINE AND 3, 5-DISUBSTITUTED PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL USE OF SAME
-
Paragraph 0365-0366, (2021/06/10)
Provided is a compound superior in an ATX inhibitory action and useful for the prophylaxis or treatment of diseases involving ATX. A carboxylic acid compound represented by the following formula (1) or a pharmacologically acceptable salt thereof: wherein each symbol is as defined in the SPECIFICATION.
3-(1-OXOISOINDOLIN-2-YL)PIPERIDINE-2,6-DIONE DERIVATIVES AND USES THEREOF
-
Paragraph 0934; 0935, (2019/03/08)
The present disclosure provides a compound of Formula (I′): or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, stereoisomer, or tautomer thereof, wherein R1, R2, Rx, X1, n, n1, and q are as defined herein, and methods of making and using same.
